52708-35-7

Usage

Application

Commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and dyes.

Structure

Contains a tetrazole ring, which is a five-membered aromatic ring comprising four nitrogen atoms and one carbon atom.

Versatility

Its unique structure and functional groups make it suitable for various chemical reactions.

Importance

Considered an important intermediate in organic synthesis.

Handling

Potentially explosive when in pure form, necessitating careful handling and storage.

Upstream product

• 288-94-8 1H-tetrazole 
• 350-46-9 4-Fluoronitrobenzene 
• 52708-38-0 2-(4-nitro-phenyl)-2H-tetrazole 

Downstream Products

• 64001-12-3 4-(2H-tetrazol-2-yl)phenol 
• 1431877-57-4 4-(2H-tetrazol-2-yl)benzenesulfonyl chloride 
• 181869-37-4 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(2H-2-tetrazolyl)phenyl]-2(1H,3H)-imidazolone 
• 325989-27-3 1-(2,2-diethoxy-ethyl)-3-(4-tetrazol-2-yl-phenyl)-urea 
• 325989-19-3 C₈H₉N₇O 
• 181870-54-2 1-[4-(2H-2-tetrazolyl)phenyl]-2(1H,3H)-imidazolone 
• 325989-13-7 (4-tetrazol-2-yl-phenyl)-carbamic acid phenyl ester 

Relevant academic research and scientific papers

IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES

Formula IA, ad their use for treating viral infections.

HIV PROTEASE INHIBITORS

Compounds of Formula I are disclosed: wherein A, R1, R2, R3, R4A, R4B, R5, R6 and R7 are defined herein. The compounds encompassed by Formula I include compounds which

SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT

Substituted cyclopropyl compounds of formula (I) are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. Pharmaceutically acceptable salts and solvates are included as well. The compounds are useful as agonists of the g-protein coupled receptor GPR-119.

Optically active antifungal azoles. X. Synthesis and antifungal activity of N-[4-(azolyl)phenyl]- and N-[4-(azolylmethyl)phenyl]-N′-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy -1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-azolones

New optically active antifungal azoles, N-[4-(azolyl)phenyl]- and N-[4-(azolylmethyl)phenyl]-N′-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy -1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]azolones (1, 2, 3), were prepared in a stereocontrolled manner. Compounds 1